Battlefield Resuscitation
Battlefield resuscitation integrates point-of-injury interventions, damage-control resuscitation, and en route care to stabilize polytrauma and hemorrhagic shock in resource-limited settings. Core elements include rapid hemorrhage control, airway and ventilatory support, balanced transfusion or low-volume temporizing fluids, and physiologic monitoring to preserve perfusion until definitive surgical care.
Technical Challenges
Massive hemorrhage and junctional/tractile wounds that are difficult to compress or tourniquet effectively
Rapid physiologic deterioration from hemorrhagic shock, traumatic brain injury, and combined blast/polytrauma
Limited forward access to blood products, warm chain logistics, and reliable transfusion capability
Environmental and operational constraints: limited power, space, lighting, and prolonged evacuation timelines
Emerging Opportunities
Portable, stable whole blood or blood-component solutions with extended shelf life for austere settings
Minimally invasive, field-deployable circulatory support (e.g., simplified REBOA-like devices) with rapid placement
Robust, low-power physiologic monitoring and decision-support that functions in noisy, chaotic environments
Scalable hemorrhage control and junctional hemostatic solutions that are easy to apply under stress and with limited training
Current and Emerging Technologies in Battlefield Resuscitation
Advanced hemorrhage control
Tourniquets, junctional tourniquets, topical hemostatic agents, and injectable pro-coagulants designed for rapid application and durable clot formation in contaminated wounds.
Forward transfusion and blood substitutes
Portable whole blood programs, lyophilized plasma, and oxygen-carrying blood substitutes aim to provide hemostatic and oxygen delivery support without cold-chain dependence.
Endovascular and hybrid circulatory tools
Field-adapted REBOA catheters, simplified occlusion devices, and hemorrhage temporization technologies to maintain perfusion to vital organs while minimizing ischemic injury.
Airway and ventilation systems
Supraglottic airways, rugged portable ventilators, and lightweight oxygen delivery/filtration systems that support respiratory failure in austere environments.
Point-of-care diagnostics and monitoring
Portable lactate, hemoglobin, viscoelastic hemostasis (VET) devices, and wearable physiologic sensors integrated with decision-support to guide resuscitation and triage.
Telemedicine and en route care platforms
Bandwidth-adaptive teleconsultation, remote visualization, and command-and-control tools that extend specialist guidance into far-forward and prolonged-field-care situations.
Importance to Military Medicine
Reduce preventable combat deaths
Rapid, effective resuscitation at point-of-injury is the single greatest modifiable factor to decrease early mortality from exsanguination and airway compromise.
Enable prolonged and distributed care
Technologies that sustain physiology during delayed evacuation preserve combat effectiveness and expand options for mission continuation and casualty stabilization.
Operate in austere, contested environments
Solutions must be rugged, low-power, rapidly deployable, and simple to use under fire or in degraded infrastructure to support battlefield medical readiness.
Preserve long-term functional outcomes
Early physiologic optimization reduces secondary injury (e.g., to brain and soft tissue), improving survival with meaningful recovery and reducing rehabilitation burden.
Alignment with the MTEC Mission
Accelerates translation of proven resuscitation technologies into operational use by supporting end-to-end development, testing, and field evaluation aligned with DoD priorities.
Fosters multidisciplinary collaboration across trauma surgery, emergency medicine, engineering, and logistics to solve bottlenecks such as blood supply and device ruggedization.
Supports rapid prototyping, clinical validation, and pivot-to-practice pathways that shorten time from concept to fielded capability for Warfighters.
Prioritizes dual-use innovation to ensure civilian trauma systems benefit from military advances and vice versa, improving overall national preparedness.
Dual-Use (Military + Civilian) Applications
Dual-use technologies support civilian mass-casualty response, rural emergency care, and prehospital blood programs, translating battlefield lessons to broader healthcare resilience.
Portable monitoring and telemedicine platforms aid EMS and disaster response teams, improving triage, remote specialist guidance, and continuity of care during prolonged transport.
Hemostatic agents, compact ventilators, and simplified endovascular tools have immediate applicability in civilian trauma centers, prehospital settings, and austere humanitarian operations.
Integration with civilian blood-banking and transfusion innovations expands supply-chain resilience and benefits both military and public health infrastructures.
Explore MTEC Members with Battlefield Resuscitation Capabilities
MTEC members combine clinical trauma expertise, device engineering, logistics, and regulatory experience to de-risk development pathways and validate technologies in realistic operational scenarios.
Consortium collaboration enables rapid access to DoD testbeds, military clinical sites, and end-user feedback loops that accelerate adoption and iterative improvement.
Explore member profiles to identify partners with turnkey capabilities in hemorrhage control, forward transfusion, monitoring, telehealth, and en route care to advance battlefield resuscitation solutions.
209 Members with Battlefield Resuscitation capabilities.
The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.

SIMETRI is a woman-and-minority owned small business based in Winter Park, Florida, specializing in modeling, simulation, and training technologies. Founded in 2009, the company focuses on delivering innovative products and services that enhance the human experience and improve client outcomes through advanced training and program management analysis.

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.

Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.

Stream Biomedical, Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class targeted therapeutics for acute neurotrauma and chronic neurodegenerative diseases. The company is dedicated to revolutionizing cerebrovascular repair and developing novel solutions for neurotrauma and neurodegeneration, including conditions such as stroke, traumatic brain injury, and Alzheimer's disease.
Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. The company focuses on purpose-driven innovation to empower healthcare professionals and enhance patient outcomes across various medical fields.

The National Foundation for Integrative Medicine (NFIM) is dedicated to transforming healthcare through innovative solutions and technologies. With a mission to shorten the technology transition cycle and improve health outcomes, NFIM focuses on patient care innovation and supports various populations, including veterans and clinicians, in accessing safer and more effective healthcare options.

Qidni Labs is a NATO DIANA company recognized by Fast Company as a 2025 World Changing Idea. The company has developed a portable, nearly waterless hemodialysis system that will make treatment accessible for over 10 million patients every year.

VirTech Bio is an early-stage biotechnology company based in Natick, Massachusetts, focused on developing a human-derived hemoglobin-based oxygen carrier (HBOC) for use as a temporary blood substitute in trauma and transplantation. The company leverages expertise in hemoglobin polymerization to address critical needs in emergency medicine and organ preservation, with a pipeline also targeting veterinary and research applications. Process innovations allow scalable and contract-based manufacturing, supported by significant non-dilutive funding from the US Department of Defense and private investment.

Maverick Labs is a U.S.-based biotechnology and materials science company specializing in advanced protein design, synthetic biology, and microbial engineering. The company operates through three tightly integrated subsidiaries—Maverick Metals, Maverick Energy, and the Maverick Bio-Gene Therapy Translational Unit—each of which applies a shared technological foundation to tackle critical challenges across national defense, energy independence, and strategic material access. Together, they develop scalable, field-ready solutions that reinforce the United States’ industrial resilience and military readiness through biotechnology-driven innovation.
Massachusetts General Hospital (Mass General) is a world-renowned academic medical center and the original and largest teaching hospital of Harvard Medical School. Mass General is recognized for its commitment to high-quality patient care, innovative research, and comprehensive educational opportunities. The hospital operates the largest hospital-based research program in the United States, fostering collaboration among leading clinicians and scientists to bridge innovation science with state-of-the-art clinical medicine. Mass General for Children (MGfC) is a leader in pediatric care, offering more than 50 medical specialties and 15 surgical services, and is home to the only proton beam facility in New England. The hospital is dedicated to serving local and global communities, training the next generation of healthcare professionals, and advancing medical knowledge through groundbreaking research, multidisciplinary care, and a strong commitment to family-centered and equitable healthcare.

STAT Therapeutics is focused on developing a drug- device combination for easy, rapid administration of intramuscular, life-saving medications by users in any setting, aiming to improve access and usability for acute emergency treatments such as pain, anaphylaxis, and seizures.

Altra Inc. is at the forefront of revolutionizing infusion therapy with its innovative Altra Infusion System. The company is dedicated to addressing the critical challenges in the infusion industry, such as mechanical failures, flow issues, and false alarms, which contribute to a significant portion of medication errors and adverse drug events. Altra's mission is to ensure patient safety and improve healthcare delivery through advanced technology solutions.

The American Burn Association (ABA) is a multidisciplinary organization dedicated to improving the lives of those affected by burn injury. With over 3,000 members worldwide, ABA focuses on promoting and supporting burn-related care, prevention, education, and research. The association brings together professionals from various disciplines to advance quality care, advocate for prevention, provide educational resources, and foster research in the field of burn injuries. ABA is also recognized for its leadership in advocacy, professional development, and the establishment of best practices and guidelines for burn care. The ABA regularly hosts conferences, develops clinical guidelines, and partners with organizations to raise awareness and improve outcomes for burn survivors.

The University of Texas at San Antonio (UTSA) is dedicated to the advancement of knowledge through research, teaching, and community engagement. As a premier public research university, UTSA embraces multicultural traditions and serves as a catalyst for socioeconomic development, providing access to educational excellence and preparing citizen leaders for the global environment.

Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.

Arizona State University
ASU Crosscutting Technologies to Enhance Military Medical Readiness and Resilience
Dr. Rachel Cassalia leads MTEC-supported efforts at ASU to shift military health from reactive care to proactive readiness through data-driven prevention.
University of Pittsburgh
Topical Metformin Lotion for Tendinopathy Prevention
University of Pittsburgh study shows topical metformin prevents overuse tendon injury. This work was sponsored through MTEC project 22-02-MPAI-014.
Theradaptive
Theradaptive’s RESTORE Trial Initiation for OsteoAdapt™ DE
Theradaptive launches RESTORE Phase I/II trial of OsteoAdapt™ DE for faster, precision bone healing in craniofacial injuries. MTEC-funded study targets improved recovery for military and civilian patients.
Altec
Autonomous Rehabilitation Device for Improved Recovery in Warfighters
The OSCIR platform—developed by Altec Inc in collaboration with the Naval Health Research Center—is bringing clinical-grade, real-time movement analysis to the front lines. Funded under MTEC-22-02-MPAI